FilingSEC EDGAR8-K
Kyntra Bio Announces Board Changes and CEO Agreement Renewal
· SEC accepted
StageCorporate Governance
Filing content
Kyntra Bio appointed Andrew E. Singer to its Board of Directors, replacing outgoing director Maykin Ho, and renewed its change-in-control and severance agreement with CEO Thane Wettig under substantially the same terms.
AI summary of the filing. Please also check the source.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…